Bartlett, J. A., Tebas, P., Bassett, R., Huang, W., Kuritzkes, D., Reisler, R., … ACTG A5064 Team, . (2003). Early intensification with abacavir in subjects at high risk for incomplete viral suppression. Antivir Ther, 8(4), 361–363.

Bartlett, John A., Pablo Tebas, Roland Bassett, Wenzheng Huang, Daniel Kuritzkes, Ronald Reisler, Nancy Loyack, Kellye Robison, and Kellye ACTG A5064 Team. “Early intensification with abacavir in subjects at high risk for incomplete viral suppression.” Antivir Ther 8, no. 4 (August 2003): 361–63.

Bartlett JA, Tebas P, Bassett R, Huang W, Kuritzkes D, Reisler R, et al. Early intensification with abacavir in subjects at high risk for incomplete viral suppression. Antivir Ther. 2003 Aug;8(4):361–3.

Bartlett, John A., et al. “Early intensification with abacavir in subjects at high risk for incomplete viral suppression.” Antivir Ther, vol. 8, no. 4, Aug. 2003, pp. 361–63.

Bartlett JA, Tebas P, Bassett R, Huang W, Kuritzkes D, Reisler R, Loyack N, Robison K, ACTG A5064 Team. Early intensification with abacavir in subjects at high risk for incomplete viral suppression. Antivir Ther. 2003 Aug;8(4):361–363.